158 / 1708
Prognostic factors
Tumour site (infratentorial / supratentorial)
progression – free survival at 5 years
Intracranial ependymoma
Author
Pat.
Tumour site Survival
p-value
Schild et al., 1998
45
Infratent. 68%
Supratent. 62%
n. s.
Timmermann
et al. 2000*
29
26
Infratent. 53.1%
Supratent. 72.4%
n. s.
Merchant 2008 et al.**
122
31
Infratent. 65.8%
Supratent. 82.9%
0.16 / n. s.
Jaing et al.,2004
28
15
Infratent. 42.5%
Supratent. 50.9%
n. s.
Mansur et al.,2005
48
12
Infratent. 65.2%
Supratent. 31.3%
n. s.
* 3 year event-free survival, ** 7 year event-free survival